X

Al finalizar la revisión de la red de la AEMPS tras el intento de ciberataque ocurrido, se concluye que no se han producido daños estructurales ni fuga de datos. En este momento se están finalizando tareas de mantenimiento y todas las aplicaciones afectadas estarán disponibles desde mañana, 22 de mayo, a las 08:00.

Disculpen las molestias

Aceptar
Logo de AEMPS
    • Castellano
    • Català
    • Euskera
    • Galego
    • Valencià
    • English
  • Inscripción en listas de distribución
  • LinkedIn AEMPS
  • Instagram AEMPS
  • YouTube AEMPS
  • X AEMPS
  • AEMPS
    • About Us
    • Public employment and scholarships
    • E-Office
    • AEMPS Procurement
    • I+D+i Projects
    • Information and assistance to citizens
    • Fees & Rates
    • COVID‑19
    • FAQs
    • Legislation
  • Medicines for human use
    • CIMA: Online Drug Information Center of the AEMPS
    • AEMPS Newsletters
    • Pharmacovigilance of medicines for human use
    • Therapeutic positioning reports
    • Research with medicines for human use
    • Medicines innovation and knowledge support office
    • Observatory on the use of medicines
    • European Union Arbitration
    • Medicine supply problems
    • Medicines in special situations
    • Non-substitutable medicines
    • Biological medicines
    • Narcotics and psychotropic substances
    • Illegal medicines
    • Legislation on medicines for human use
    • Homeopathics
    • Strategic medicines
    • Non-industrially manufactured drugs
    • Pharmacogenetics biomarkers
  • Veterinary medicines
    • CIMA Vet: AEMPS Online Information Center for Veterinary Medicines
    • AEMPS bulletin on veterinary medicines
    • Clinical research with veterinary medicines
    • Narcotics and psychotropics in veterinary medicine
    • Manufacture of drugs and active ingredients
    • Distance sales of veterinary medicines
    • Illegal veterinary medicines
    • Legislation on veterinary medicines
    • Pharmacovigilance of veterinary medicines
    • Prescription of veterinary medicines
    • Allergen-based medicines
  • Medical devices
    • Publications on medical devices
    • Medical devices
    • Marketing of medical devices in Spain
    • In vitro diagnostic medical devices
    • Clinical investigations with medical devices
    • Medical device surveillance
    • Registration of implantable medical devices
    • Notification of incidents involving medical devices
    • Legislation on medical devices
    • Breast implants
    • Guide for the pacemaker wearer
  • Cosmetics
    • Sanitary guarantees of cosmetic products
    • Cosmetics
    • Publications on cosmetics, biocides, AEMPS and personal care products
    • Legislation on cosmetic products
    • Cosmetovigilance
  • Biocides and personal care products
    • AEMPS Biocides
    • Personal care products
    • Legislation on biocides
    • Legislation on personal care products
    • Publications on cosmetics, biocides, AEMPS and personal care products
  • Press
    • AEMPS Information notes
    • AEMPS Publications
    • Institutional campaigns
    • Alerts
    • Scientific Articles
    • Events
    • Security Notes
    • AEMPS distribution lists
    • Training for researchers
  • Pharmaceutical Industry
    • Pharmaceutical laboratories: authorization, modification and registration
    • Medicines Registry
    • Inspection and Control
    • Active Ingredients: manufacturing, import and delivery
    • Labeling and Leaflets
    • Safety features of Medicines for Human Use
    • Human Pharmacovigilance: Pharmaceutical Industry
    • Commercialization of medicines
    • Fees & Rates
    • Industry and Delivery Regulation
    • Pharmaceutical delivery
    • Foreign trade
    • Allergen-based medicines
  • Healthcare Professionals
    • Pharmacies and hospital pharmacy services
    • Procedure for notification of drug movements: Pharmacies and pharmacy services
    • Medicine Supply Problems
    • Online legal sale of medicines for human use without prescription
    • Contact Points for foreign medicines in the Autonomous Regions
    • Notifications of Adverse Reactions
    • Non substituted medicines
    • Online sale of veterinary medicines
    • Pharmacopoeia and Master Formulation
    • Medicines Quality Issues
  • Citizens
    • CIMA: AEMPS Medicines for Human Use Online Information Center
    • Medicines subject of additional monitoring
    • Medicines and Driving
    • Medicine Supply Problems
    • AEMPS Publications
    • Informative brochures
    • Institutional campaigns
    • Ilegal Medicines
    • Information and assistance to citizens
    • Charter of services
    • Notifications of Adverse Reactions
    • Public participation in regulatory projects
    • Medicines and heat
  • CNCps
Inscripción en listas de distribución LinkedIn AEMPS Instagram AEMPS YouTube AEMPS X AEMPS
  • Castellano
  • Català
  • Euskera
  • Galego
  • Valencià
  • English
portada sgicm

Departamento de Inspección y Control de Medicamentos

Inicio > La AEMPS > Estructura, departamentos y órganos de la AEMPS > Departamento de Inspección y Control de Medicamentos
Fecha de actualización: 23 de enero de 2024
  • Funciones y estructura
  • Inspección de Normas de Correcta Fabricación
  • Inspección de Buenas Prácticas de Laboratorio
  • Inspección de Buena Práctica Clínica
  • Alertas de calidad
  • Estupefacientes y Psicótropos
  • Donaciones de medicamentos
  • Comité Técnico de Inspección
  • Catálogo de entidades de distribución
  • Registro de Laboratorios Farmacéuticos
  • Inicio
  • Aviso legal
  • Mapa Web
  • Accesibilidad
  • Protección de datos
Inscripción en listas de distribución LinkedIn AEMPS Instagram AEMPS YouTube AEMPS X AEMPS
Isotipo AEMPS

Agencia Española de Medicamentos y Productos Sanitarios (AEMPS)
C/ Campezo nº 1, Edificio 8
28022, Madrid

Ministerio de Sanidad Sello Excelencia CAF